Quick Answer
BIOREGENX, INC. reported Total Revenue of $2.34 million for fiscal year 2024.
BIOREGENX, INC. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2024 | $2.34M | -31.4% |
| 2023 | $3.41M | +7991.8% |
| 2022 | $42.2K | -78.8% |
| 2021 | $198.6K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $507.8K | -14.8% | +13.9% |
| June 30, 2025 | $446.0K | -39.2% | -13.4% |
| March 31, 2025 | $515.1K | -6.3% | -13.6% |
| September 30, 2024 | $596.0K | -25.0% | -18.8% |
| June 30, 2024 | $734.0K | -15.0% | +33.6% |
| March 31, 2024 | $549.5K | +9798.2% | -30.8% |
| September 30, 2023 | $794.5K | +6942.0% | -8.0% |
| June 30, 2023 | $863.3K | +5954.7% | +15449.0% |
- BIOREGENX, INC. showed a decrease of -31.4% in Total Revenue compared to the prior fiscal year.
- Over the 2021–2024 period, BIOREGENX, INC.’s total revenue has grown by 1078.4% (from $198.6 thousand to $2.34 million).
- The most recent figure is from BIOREGENX, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: